DD
Dearen Danny L.
Executive
OtherM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Dearen Danny L., Executive. Officer active across 2 companies, notably Axonics, Inc.. Cumulatively, 21 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.5m. Activity tracked since 20 May 2021. The latest transaction was disclosed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations21 total
16,965 shares0Common StockSEC:0001756438-26-000003:0
11,247 shares0Common StockSEC:0001415889-25-008535:0
36,919 shares0Common StockSEC:0001562180-23-007189:0
11,250 shares0Common StockSEC:0001562180-23-007190:0
7,699 shares@ US$49.43559.7% of flowCommon StockSEC:0001562180-23-004641:0
13,208 shares@ US$14.194.7% of flowCommon StockSEC:0001562180-23-003685:0
10,363 shares@ US$59.930815.5% of flowCommon StockSEC:0001562180-23-003685:1
9,637 shares@ US$60.503714.6% of flowCommon StockSEC:0001562180-23-003685:2
2,001 shares@ US$14.190.7% of flowCommon StockSEC:0001562180-23-003669:0
6,633 shares@ US$14.192.4% of flowCommon StockSEC:0001562180-23-003425:0
5,000 shares0Common StockSEC:0001562180-23-000874:0
656 shares@ US$75.601.4% of flowCommon StockSEC:0001562180-22-006685:0
1,616 shares@ US$1.320.1% of flowCommon StockSEC:0001562180-22-006102:0
12,329 shares@ US$25.8215.2% of flowCommon StockSEC:0001562180-22-002348:0
6,421 shares@ US$25.828.0% of flowCommon StockSEC:0001562180-22-002063:0
20,000 shares@ US$14.1913.6% of flowCommon StockSEC:0001562180-22-001105:0
20,000 shares@ US$14.1935.3% of flowCommon StockSEC:0001562180-22-001105
10,805 shares@ US$14.1918.8% of flowCommon StockSEC:0001562180-22-000563
10,805 shares@ US$14.197.2% of flowCommon StockSEC:0001562180-22-000563:0
28,291 shares@ US$14.1917.6% of flowCommon StockSEC:0001562180-21-003716:0
28,291 shares@ US$14.1917.6% of flowCommon StockSEC:0001562180-21-003716
About Dearen Danny L.
Danny L. Dearen is an executive at Axonics, Inc. While his specific role is not detailed, he contributes to the management and strategy of the company. Danny brings expertise that supports growth and innovation initiatives within Axonics. His commitment to operational excellence is an asset to the organization.